Product Information
LANSOPRAZOLE DR 15 MG CAPSULE is a generic product labeled by Cardinal Health, priced at $0.4323 per EA under NDC 70000061201. Its NADAC has been published 49 times since Apr 30, 2025.
FDA first approved this application on May 18, 2012.
Strength
15 mg/1
Manufacturer
Cardinal HealthNDC
70000061201
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202194FDA Approved
5/18/2012
On Market Since
10/26/2022
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has been published 49 times since Apr 30, 2025, and over the history we have for it it has declined 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4323 per EA |
|---|---|
| All-time high | $0.4594 (May 14, 2025) |
| All-time low | $0.4184 (Jan 21, 2026) |
| 52-week high | $0.4502 |
| 52-week low | $0.4184 |
| Median price | $0.4348 |
| Average price | $0.4356 |
| Largest weekly change | -3.9% (May 21, 2025) |
| Weeks tracked | 49 |
| Tracking since | Apr 30, 2025 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-4.0%
3Y
N/A
5Y
N/A
All
-5.9%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lansoprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 15 MG CAPSULE, manufactured by Cardinal Health, is $0.4323 per EA (NDC 70000061201), effective Apr 1, 2026.
How has the price of LANSOPRAZOLE DR 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has declined 5.9%. It has been tracked across 49 weekly CMS publications since Apr 30, 2025.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 15 MG CAPSULE?
Since Apr 30, 2025, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has ranged from a low of $0.4184 (Jan 21, 2026) to a high of $0.4594 (May 14, 2025), with a median of $0.4348 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 15 MG CAPSULE?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 15 MG CAPSULE, is $0.1474 per EA — about 66% below LANSOPRAZOLE DR 15 MG CAPSULE.
Who manufactures LANSOPRAZOLE DR 15 MG CAPSULE?
LANSOPRAZOLE DR 15 MG CAPSULE (NDC 70000061201) is labeled by Cardinal Health, and CMS classifies it as a generic product.